Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study

2021-12-05T10:39:30+00:00December 5th, 2021|

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study Effect on survival CONTACT US Summary This study investigates the effects of Electro-hyperthermia on [...]

Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer

2021-12-05T10:20:39+00:00December 5th, 2021|

Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer CT scan. CONTACT US Summary This study investigates, DC-based immunotherapy, in conjunction with toll-like receptor (TLR)-3 [...]

Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients

2021-12-05T09:35:04+00:00December 5th, 2021|

Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients Increased blood pressure, or rhythm changes during mEHT treatments. CONTACT US [...]

Dendritic Cell-based Immunotherapy Pulsed with Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial

2021-11-22T14:47:42+00:00November 19th, 2021|

Dendritic Cell-based Immunotherapy Pulsed with Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial Survival rate CONTACT [...]

Go to Top